BPC
RARE icon

Bryce Point Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History

Bryce Point Capital’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-10,719
Closed -$451K – 396
2024
Q4 		$451K Buy
+10,719
New +$451K 0.13% 363